JESSICA LIANG,MAHAVIR PRASHAD,PAUL ALLEN SUTTON,MICHAEL J. GIRGIS,EDWIN BERNARD VILLHAUER
申请号：
PT13197714
公开号：
PT2781516T
申请日:
2011.10.05
申请国别(地区):
PT
年份:
2017
代理人:
摘要：
The present invention relates to novel crystalline forms of (4-{4-[5-(6-Trifluoromethylpyridin-3-ylamino)-pyridin-2-yl]-phenyl}-cyclohexyl)-acetic acid, sodium and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans. It also relates processes for making such novel crystalline forms.
